Wenge Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wenge Liu has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Ashutosh Chilkoti
Department of Biomedical Engineering Duke University Durham North Carolina USA
11 shared publications Michael R. Zalutsky
Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Radiology, Duke University, Durham, NC 27708, USA
11 shared publicationsAshutosh Chilkoti
Department of Biomedical Engineering, Duke University, Durham, NC, 27708, USA
7 shared publicationsMatthew R. Dreher
Center for Interventional Oncology, Clinical Center, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United States
6 shared publicationsXinghai Li
Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
6 shared publications- Jeffrey Laurence Schaal
Department of Biomedical Engineering, Duke University, Durham, NC, USA
4 shared publications
Latest Publications
- 7 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 131-136
A Photovoltaic-Energy Storage Joint System Assisted Scheme for Seamless Closed-Loop Load Transfer
To meet the demand of energy transformation, a large number of photovoltaic system and energy storage are widely connected to the distribution network. This paper proposes a seamless closed-loop load transfer scheme assisted by photovoltaic-energy storage joint system. This scheme is implemented by using photovoltaic energy storage to jointly carry the load for a short time, and adjusting the inverter voltage and current synchronization with the standby power grid. The simulation including amplitude difference and phase angle difference is carried out on the MATLAB/Simulink simulation platform. The simulation show that this scheme can eliminate the phase angle difference and amplitude difference on both sides of the contact switch, improve the safety of the loop closing operation, and reduce the impact current and circulating current of the loop closing on the distribution network.
- 7 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 131-136
A Photovoltaic-Energy Storage Joint System Assisted Scheme for Seamless Closed-Loop Load Transfer
To meet the demand of energy transformation, a large number of photovoltaic system and energy storage are widely connected to the distribution network. This paper proposes a seamless closed-loop load transfer scheme assisted by photovoltaic-energy storage joint system. This scheme is implemented by using photovoltaic energy storage to jointly carry the load for a short time, and adjusting the inverter voltage and current synchronization with the standby power grid. The simulation including amplitude difference and phase angle difference is carried out on the MATLAB/Simulink simulation platform. The simulation show that this scheme can eliminate the phase angle difference and amplitude difference on both sides of the contact switch, improve the safety of the loop closing operation, and reduce the impact current and circulating current of the loop closing on the distribution network.
- 13 June 2016
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 61 (10) , 2921-2927
Brachytherapy Using Elastin-Like Polypeptides with 131I Inhibit Tumor Growth in Rabbits with VX2 Liver Tumor
Background Brachytherapy is a targeted type of radiotherapy utilized in the treatment of cancers. Elastin-like polypeptides are a unique class of genetically engineered peptide polymers that have several attractive properties for brachytherapy. Aims To explore the feasibility and application of brachytherapy for VX2 liver tumor using elastin-like polypeptides with 131I so as to provide reliable experimental evidence for a new promising treatment of liver cancer. Methods Elastin-like polypeptide as carrier was labeled with 131I using the iodogen method. Ten eligible rabbits with VX2 liver tumor were randomly divided into the treatment group (n = 5) and control group (n = 5). The treatment group received brachytherapy using elastin-like polypeptide with 131I, and in the control group, elastin-like polypeptide was injected into the VX2 liver tumor as a control. Periodic biochemical and imaging surveillances were required to assess treatment efficacy. Results The stability of elastin-like polypeptide with 131I in vitro was maintained at over 96.8 % for 96 h. Biochemistry and imaging indicated brachytherapy using elastin-like polypeptide with 131I for liver tumor can improve liver function and inhibit tumor growth (P < 0.05). Conclusions Elastin-like polypeptide can be an ideal carrier of 131I and have high labeling efficiency, radiochemical purity and stability. Brachytherapy using elastin-like polypeptide with 131I for liver tumor is a useful therapy that possesses high antitumor efficacy advantages.
- 13 June 2016
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 61 (10) , 2921-2927
Brachytherapy Using Elastin-Like Polypeptides with 131I Inhibit Tumor Growth in Rabbits with VX2 Liver Tumor
Background Brachytherapy is a targeted type of radiotherapy utilized in the treatment of cancers. Elastin-like polypeptides are a unique class of genetically engineered peptide polymers that have several attractive properties for brachytherapy. Aims To explore the feasibility and application of brachytherapy for VX2 liver tumor using elastin-like polypeptides with 131I so as to provide reliable experimental evidence for a new promising treatment of liver cancer. Methods Elastin-like polypeptide as carrier was labeled with 131I using the iodogen method. Ten eligible rabbits with VX2 liver tumor were randomly divided into the treatment group (n = 5) and control group (n = 5). The treatment group received brachytherapy using elastin-like polypeptide with 131I, and in the control group, elastin-like polypeptide was injected into the VX2 liver tumor as a control. Periodic biochemical and imaging surveillances were required to assess treatment efficacy. Results The stability of elastin-like polypeptide with 131I in vitro was maintained at over 96.8 % for 96 h. Biochemistry and imaging indicated brachytherapy using elastin-like polypeptide with 131I for liver tumor can improve liver function and inhibit tumor growth (P < 0.05). Conclusions Elastin-like polypeptide can be an ideal carrier of 131I and have high labeling efficiency, radiochemical purity and stability. Brachytherapy using elastin-like polypeptide with 131I for liver tumor is a useful therapy that possesses high antitumor efficacy advantages.
- 1 April 2016
- Published by Elsevier in Journal of Controlled Release
- Vol. 228, 58-66
Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy
- 1 April 2016
- Published by Elsevier in Journal of Controlled Release
- Vol. 228, 58-66
Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy
- 1 February 2016
- Published by Elsevier in Biomaterials
- Vol. 79, 79-87
Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor
- 1 February 2016
- Published by Elsevier in Biomaterials
- Vol. 79, 79-87
Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor
- 1 November 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 82 (5) , 944-952
A feasibility study of a thermally sensitive elastin-like polypeptide for submucosal injection application in endoscopic resection in 3 animal models
- 1 November 2015
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 82 (5) , 944-952
A feasibility study of a thermally sensitive elastin-like polypeptide for submucosal injection application in endoscopic resection in 3 animal models
- 1 August 2015
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 75 (15_Supplem) , 1809
Abstract 1809: Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model
The intratumoral delivery of radioactive therapeutics, a clinical technique known as brachytherapy, has proven very successful in treating solid cancers and become a prevalent option for treating prostate, breast, and melanoma tumors. The method typically involves the permanent implantation of 80-120 titanium ‘seeds’ encapsulating radioactive isotopes and requires expert spatial placement to ensure full dose coverage. The disadvantages of the seeds include a complicated implantation process, the permanence of the implants, migration of seeds to off-target sites, and that the titanium shielding limits the application of radionuclides which could treat more aggressive forms of cancer. As such, we have developed a next-generation brachytherapy alternative to solid seeds using an injectable, biodegradable, biocompatible and thermosensitive elastin-like polypeptide (ELP). Through recombinant design and synthesis, ELP exhibits a thermal phase transition (soluble-to-insoluble) when heated above 21°C. This allows radionuclide-bearing ELP to be easily handled as a fluid at room temperature, but enables spontaneous self-assembly into a stable brachytherapy gel upon intratumoral injection at body temperature. Previously, we demonstrated the efficacy of ELP brachytherapy in treating both s.c. human hypopharyngeal tumors and orthotopic human prostate tumors xenografted in mice models.
- 1 August 2015
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 75 (15_Supplem) , 1809
Abstract 1809: Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model
The intratumoral delivery of radioactive therapeutics, a clinical technique known as brachytherapy, has proven very successful in treating solid cancers and become a prevalent option for treating prostate, breast, and melanoma tumors. The method typically involves the permanent implantation of 80-120 titanium ‘seeds’ encapsulating radioactive isotopes and requires expert spatial placement to ensure full dose coverage. The disadvantages of the seeds include a complicated implantation process, the permanence of the implants, migration of seeds to off-target sites, and that the titanium shielding limits the application of radionuclides which could treat more aggressive forms of cancer. As such, we have developed a next-generation brachytherapy alternative to solid seeds using an injectable, biodegradable, biocompatible and thermosensitive elastin-like polypeptide (ELP). Through recombinant design and synthesis, ELP exhibits a thermal phase transition (soluble-to-insoluble) when heated above 21°C. This allows radionuclide-bearing ELP to be easily handled as a fluid at room temperature, but enables spontaneous self-assembly into a stable brachytherapy gel upon intratumoral injection at body temperature. Previously, we demonstrated the efficacy of ELP brachytherapy in treating both s.c. human hypopharyngeal tumors and orthotopic human prostate tumors xenografted in mice models.
- 26 November 2014
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (3) , 1002-1006
Ring‐Opening Polymerization of Prodrugs: A Versatile Approach to Prepare Well‐Defined Drug‐Loaded Nanoparticles
The synthesis of polymer–drug conjugates from prodrug monomers consisting of a cyclic polymerizable group that is appended to a drug through a cleavable linker is achieved by organocatalyzed ring‐opening polymerization. The monomers polymerize into well‐defined polymer prodrugs that are designed to self‐assemble into nanoparticles and release the drug in response to a physiologically relevant stimulus. This method is compatible with structurally diverse drugs and allows different drugs to be copolymerized with quantitative conversion of the monomers. The drug loading can be controlled by adjusting the monomer(s)/initiator feed ratio and drug release can be encoded into the polymer by the choice of linker. Initiating these monomers from a poly(ethylene glycol) macroinitiator results in amphiphilic diblock copolymers that spontaneously self‐assemble into micelles with a long plasma circulation, which is useful for systemic therapy.
- 26 November 2014
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (3) , 1002-1006
Ring‐Opening Polymerization of Prodrugs: A Versatile Approach to Prepare Well‐Defined Drug‐Loaded Nanoparticles
The synthesis of polymer–drug conjugates from prodrug monomers consisting of a cyclic polymerizable group that is appended to a drug through a cleavable linker is achieved by organocatalyzed ring‐opening polymerization. The monomers polymerize into well‐defined polymer prodrugs that are designed to self‐assemble into nanoparticles and release the drug in response to a physiologically relevant stimulus. This method is compatible with structurally diverse drugs and allows different drugs to be copolymerized with quantitative conversion of the monomers. The drug loading can be controlled by adjusting the monomer(s)/initiator feed ratio and drug release can be encoded into the polymer by the choice of linker. Initiating these monomers from a poly(ethylene glycol) macroinitiator results in amphiphilic diblock copolymers that spontaneously self‐assemble into micelles with a long plasma circulation, which is useful for systemic therapy.
- 14 November 2012
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (22) , 5956-5965
Brachytherapy Using Injectable Seeds That Are Self-Assembled from Genetically Encoded Polypeptides In Situ
Brachytherapy is a common clinical technique involving implantation of sealed radioactive “seeds” within a tumor to selectively irradiate the tumor mass while minimizing systemic toxicity. To mitigate the disadvantages associated with complex surgical implantation and subsequent device removal procedures, we have developed an alternative approach using a genetically encoded peptide polymer solution composed of a thermally responsive elastin-like polypeptide (ELP) radiolabeled with 131I that self-assembles into radionuclide seeds upon intratumoral injection. The formation of these nontoxic and biodegradable polymer seeds led to prolonged intratumoral retention (∼85% ID/tumor 7 days postinjection) of the radionuclide, elicited a tumor growth delay in 100% of the tumors in two human xenografts (FaDu and PC-3), and cured more than 67% of tumor-bearing animals after a single administration of labeled ELP. These results suggest that in situ self-assembly of biodegradable and injectable radionuclide-containing polypeptide seeds could be a promising therapeutic alternative to conventional brachytherapy. Cancer Res; 72(22); 5956–65. ©2012 AACR.
- 14 November 2012
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (22) , 5956-5965
Brachytherapy Using Injectable Seeds That Are Self-Assembled from Genetically Encoded Polypeptides In Situ
Brachytherapy is a common clinical technique involving implantation of sealed radioactive “seeds” within a tumor to selectively irradiate the tumor mass while minimizing systemic toxicity. To mitigate the disadvantages associated with complex surgical implantation and subsequent device removal procedures, we have developed an alternative approach using a genetically encoded peptide polymer solution composed of a thermally responsive elastin-like polypeptide (ELP) radiolabeled with 131I that self-assembles into radionuclide seeds upon intratumoral injection. The formation of these nontoxic and biodegradable polymer seeds led to prolonged intratumoral retention (∼85% ID/tumor 7 days postinjection) of the radionuclide, elicited a tumor growth delay in 100% of the tumors in two human xenografts (FaDu and PC-3), and cured more than 67% of tumor-bearing animals after a single administration of labeled ELP. These results suggest that in situ self-assembly of biodegradable and injectable radionuclide-containing polypeptide seeds could be a promising therapeutic alternative to conventional brachytherapy. Cancer Res; 72(22); 5956–65. ©2012 AACR.
- 26 August 2012
- Published by Wiley in Digestive Endoscopy
- Vol. 24 (5) , 374-377
Synchronous presentation of acute pancreatitis and splenomegaly with intussusceptions in Peutz-Jeghers syndrome
Peutz-Jeghers syndrome (PJS) is a rare, autosomal dominant inherited disorder characterized by gastrointestinal hamartomatous polyps and pigmented mucocutaneous lesions. Intussusceptions and gastrointestinal tract bleeding are frequent complications of PJS caused by larger polyps, but acute pancreatitis and splenomegaly are very rare. Previously, surgical intervention was the only curative modality despite the associated complications. In recent years, double-balloon enteroscopy (DBE) has become the alternative method as the ideal treatment. We report the case of a 20-year-old woman diagnosed with PJS, as she suffered from 4-day nausea and vomiting with acute abdominal pain, and clinically manifested acute pancreatitis, splenomegaly and duodenojejunal intussusceptions secondary to a huge proximal jejunal polyp (10 cm × 2 cm). We removed the polyp via DBE and found that the acute pancreatitis, splenomegaly and duodenojejunal intussusceptions were simultaneously ameliorated 2 days after treatment. Currently, the patient has been symptom free for 3 months after polypectomy. Acute pancreatitis, splenomegaly and intussusceptions can synchronously occur in PJS patients, and polypectomy via DBE is the effective treatment alternative to surgical intervention for this disease, thereby obviating some complications associated with the latter.
- 26 August 2012
- Published by Wiley in Digestive Endoscopy
- Vol. 24 (5) , 374-377
Synchronous presentation of acute pancreatitis and splenomegaly with intussusceptions in Peutz-Jeghers syndrome
Peutz-Jeghers syndrome (PJS) is a rare, autosomal dominant inherited disorder characterized by gastrointestinal hamartomatous polyps and pigmented mucocutaneous lesions. Intussusceptions and gastrointestinal tract bleeding are frequent complications of PJS caused by larger polyps, but acute pancreatitis and splenomegaly are very rare. Previously, surgical intervention was the only curative modality despite the associated complications. In recent years, double-balloon enteroscopy (DBE) has become the alternative method as the ideal treatment. We report the case of a 20-year-old woman diagnosed with PJS, as she suffered from 4-day nausea and vomiting with acute abdominal pain, and clinically manifested acute pancreatitis, splenomegaly and duodenojejunal intussusceptions secondary to a huge proximal jejunal polyp (10 cm × 2 cm). We removed the polyp via DBE and found that the acute pancreatitis, splenomegaly and duodenojejunal intussusceptions were simultaneously ameliorated 2 days after treatment. Currently, the patient has been symptom free for 3 months after polypectomy. Acute pancreatitis, splenomegaly and intussusceptions can synchronously occur in PJS patients, and polypectomy via DBE is the effective treatment alternative to surgical intervention for this disease, thereby obviating some complications associated with the latter.
- 1 July 2012
- Published by Elsevier in Biomaterials
- Vol. 33 (21) , 5451-5458
Protein polymer hydrogels by in situ, rapid and reversible self-gelation
- 1 July 2012
- Published by Elsevier in Biomaterials
- Vol. 33 (21) , 5451-5458
Protein polymer hydrogels by in situ, rapid and reversible self-gelation